Nalaganje...
Neoadjuvant therapy for resectable pancreatic ductal adenocarcinoma: The need for patient-centered research
Pancreatic ductal adenocarcinoma is an aggressive cancer with high recurrence rates following surgical resection. While adjuvant chemotherapy improves survival, a significant proportion of patients are unable to initiate or complete all intended therapy following pancreatectomy due to postoperative...
Shranjeno v:
| izdano v: | World J Gastroenterol |
|---|---|
| Main Authors: | , , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Baishideng Publishing Group Inc
2020
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7002907/ https://ncbi.nlm.nih.gov/pubmed/32063686 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3748/wjg.v26.i4.375 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|